Mode
Text Size
Log in / Sign up

MONO, ORM1, ORM2, and AGP levels show excellent diagnostic value for psoriasis identification in a retrospective case-control study.

MONO, ORM1, ORM2, and AGP levels show excellent diagnostic value for psoriasis identification in a r…
Photo by Navy Medicine / Unsplash
Key Takeaway
Note excellent diagnostic AUC of 0.888 for psoriasis identification using MONO, ORM1, ORM2, and AGP levels in this retrospective study.

This retrospective case-control study assessed the diagnostic utility of MONO, ORM1, ORM2, and AGP levels for identifying psoriasis. The population comprised 140 participants, consisting of 70 patients with psoriasis confirmed by the dermatology department and 70 healthy individuals undergoing routine health examinations. The setting included both the dermatology department and routine health examination contexts. No follow-up duration was reported for this study.

The primary outcome measured the overall predictive ability of the model, which was described as excellent with an AUC of 0.888 (95% CI: 0.835–0.941). Individual biomarker performance varied: ORM2 showed an AUC of 0.777, ORM1 an AUC of 0.720, AGP an AUC of 0.673, and MONO an AUC of 0.638. Specific p-values or confidence intervals were not reported for the individual biomarkers.

Safety and tolerability data were not reported, as were adverse events, serious adverse events, or discontinuations. Funding or conflicts of interest were not reported. The study limitations include its retrospective case-control design, which precludes causal inference, and the absence of reported follow-up or safety monitoring. Practice relevance notes that these research results should be applied to clinical settings with appropriate caution.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Psoriasis is a complex chronic inflammatory skin disease. While typical cases are often diagnosed based on clinical features, achieving objective assessment of disease activity and precise early-stage identification remains a clinical focus. This study aims to evaluate the diagnostic value of monocytes (MONO), Orosomucoid-1 (ORM1), Orosomucoid-2 (ORM2), and Alpha-1-acid glycoprotein (AGP), and to develop a nomogram for the objective and early identification of psoriasis. This retrospective case-control study included 140 participants, comprising 70 patients with psoriasis confirmed by the dermatology department and 70 healthy individuals who underwent routine health examinations during the same period. Demographic, clinical, and laboratory data (including MONO, ORM1, ORM2, and AGP) were collected for all participants. Potential risk factors were initially screened using univariate Logistic regression, followed by feature selection via the combination of Lasso regression and Boruta algorithm to identify features with the highest predictive value. Restricted cubic spline (RCS) plots were utilized to visually illustrate the non-linear associations between the selected variables and the risk of psoriasis onset. Finally, the selected features were incorporated into a multivariate Logistic regression model to determine the independent risk factors, and a diagnostic nomogram was constructed accordingly. Based on the results of univariate analysis, LASSO regression and Boruta algorithm, we ultimately selected four key variables, namely MONO, ORM1, ORM2 and AGP, for the construction of the subsequent multivariate diagnostic model. The calibration curve of the model showed that the actual probability was highly consistent with the predicted probability, indicating that the model had good calibration performance. The receiver operating characteristic (ROC) curve indicated that the overall predictive ability of the model was excellent, with an area under curve (AUC) of 0.888 (95% CI: 0.835–0.941). In addition, the ROC curves of each variable analyzed separately showed that ORM2 (AUC = 0.777), ORM1 (AUC = 0.720), MONO (AUC = 0.638) and AGP (AUC = 0.673) all had different degrees of predictive ability for the risk of psoriasis. The novel biomarker combinations with stable and high expression in the early stage have shown great potential in the research of psoriasis. These research results should be applied to clinical.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.